Harmony Biosciences Holdings, INC. (HRMY) — 8-K Filings

8-K Filings (16)

• Harmony Biosciences Files 8-K: Officer/Director Changes & Exhibits — Apr 14, 2026 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on April 14, 2026, reporting changes in officers and directors under Item 5.02, a Regulation FD disclosure under
• Harmony Biosciences Files 8-K on Financials — Oct 23, 2025 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on October 23, 2025, reporting on its results of operations and financial condition. The filing includes financi
• Harmony Biosciences Files 8-K — Sep 24, 2025 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on September 24, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibit
• Harmony Biosciences Files 8-K — Jun 11, 2025 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on June 11, 2025, reporting on Regulation FD disclosures and financial statements. The filing does not contain s
• Harmony Biosciences Files 8-K — Jun 5, 2025 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on June 5, 2025, reporting on other events and financial statements. The filing details the company's principal
• Harmony Biosciences Files 8-K on Shareholder Vote Matters — May 15, 2025 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on May 15, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain d
• Harmony Biosciences Files 8-K: Director/Officer Changes & Compensation — Apr 3, 2025 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on April 3, 2025, reporting changes in directors and officers, and compensatory arrangements. The filing also in
• Harmony Biosciences Reports Officer/Director Changes & Compensation — Mar 24, 2025 Risk: medium
  Harmony Biosciences Holdings, Inc. filed an 8-K on March 24, 2025, reporting events as of March 20, 2025. The filing primarily concerns the departure of directo
• Harmony Biosciences Files 8-K on Financials — Jan 13, 2025 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes Re
• Harmony Biosciences Files 8-K — Nov 1, 2024 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on November 1, 2024, reporting an event that occurred on October 30, 2024. The filing pertains to 'Other Events'
• 8-K Filing — Oct 1, 2024
• Harmony Biosciences Announces Executive Appointments and Departures — Jul 1, 2024 Risk: medium
  Harmony Biosciences Holdings, Inc. announced on June 27, 2024, a series of executive changes. Dr. Jeffrey M. Dayno has been appointed Chief Medical Officer, and
• Harmony Biosciences Files 8-K on Shareholder Vote Matters — May 29, 2024 Risk: low
  Harmony Biosciences Holdings, Inc. filed an 8-K on May 29, 2024, to report on matters submitted to a vote of its security holders. The filing does not detail th
• Harmony Biosciences Reports Officer/Director Changes & Compensatory Info — May 3, 2024 Risk: medium
  Harmony Biosciences Holdings, Inc. filed an 8-K on May 3, 2024, reporting events as of May 1, 2024. The filing primarily concerns the departure of directors or
• Harmony Biosciences Enters Material Definitive Agreement — Apr 11, 2024 Risk: medium
  Harmony Biosciences Holdings, Inc. announced on April 6, 2024, the entry into a material definitive agreement. The company, incorporated in Delaware with IRS nu
• Harmony Biosciences Files 8-K on Financial Condition — Jan 8, 2024
  Harmony Biosciences Holdings, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition. This filing, under the Secur

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX